Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 840 | 724 | 0.0166 | 0.0153 | 0.8619 | 0.8976 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 840 | 273 | 0.4343 | 0.3712 | 0.3250 | 0.3204 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 843 | 145 | 0.7067 | 0.5785 | 0.1720 | 0.1867 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 850 | 32 | 0.6527 | 0.8133 | 0.0376 | 0.0417 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 850 | 795 | 0.0065 | 0.0047 | 0.9353 | 0.9535 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 854 | 49 | 0.7905 | 0.7915 | 0.0574 | 0.0491 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 855 | 222 | 0.5051 | 0.5481 | 0.2596 | 0.2669 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 1 | 856 | 414 | 0.1342 | 0.2031 | 0.4836 | 0.4582 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 858 | 500 | 0.0646 | 0.0793 | 0.5828 | 0.5384 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 859 | 138 | 0.7300 | 0.6679 | 0.1607 | 0.1517 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 859 | 151 | 0.5423 | 0.5371 | 0.1758 | 0.1786 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 1 | 860 | 78 | 0.7679 | 0.6000 | 0.0907 | 0.1021 |
MZ7-mel | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 862 | 123 | 0.1624 | 0.2476 | 0.1427 | 0.1178 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 862 | 273 | 0.4511 | 0.3972 | 0.3167 | 0.3126 |
MZ7-mel | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 3 | 863 | 158 | 0.2034 | 0.1862 | 0.1831 | 0.1658 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 864 | 753 | 0.0132 | 0.0137 | 0.8715 | 0.8777 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 865 | 273 | 0.5994 | 0.5184 | 0.3156 | 0.2893 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 867 | 41 | 0.6326 | 0.6038 | 0.0473 | 0.0460 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 868 | 106 | 0.7483 | 0.6759 | 0.1221 | 0.1363 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 869 | 203 | 0.1463 | 0.2468 | 0.2336 | 0.2247 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 869 | 37 | 0.8424 | 0.8032 | 0.0426 | 0.0480 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 871 | 154 | 0.7041 | 0.6805 | 0.1768 | 0.1572 |
MZ7-mel | Vemurafenib | Dasatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 873 | 185 | 0.1384 | 0.1382 | 0.2119 | 0.2130 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 873 | 73 | 0.6127 | 0.5614 | 0.0836 | 0.0959 |
MZ7-mel | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 875 | 69 | 0.1621 | 0.2297 | 0.0789 | 0.0870 |